The clinically applied PARP inhibitor talazoparib ameliorates imiquimod-induced psoriasis in mice without reducing skin inflammation

Considering the role PARPs play in inflammation, we assessed the effect of PARP inhibition in an inflammatory skin condition, psoriasis, to explore novel avenues for the potential repurposing of PARP inhibitors that are currently used in tumour therapy. The imiquimod (IMQ)-induced model of psoriasis...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Frontiers in pharmacology Jg. 16; S. 1519066
Hauptverfasser:	Molnár, Petra, Demény, Máté Ágoston, Várkonyi, Beáta, Polgár, Zsuzsanna, Pór, Ágnes, Kovács, Ilona, Szegedi, Andrea, Szöllősi, Attila Gábor, Szántó, Magdolna
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland Frontiers Media S.A 19.02.2025
Schlagworte:	apoptosis drug repurposing mitochondria PARP inhibitor Pharmacology psoriasis terminal differentiation apoptosis drug repurposing terminal differentiation mitochondria psoriasis PARP inhibitor
ISSN:	1663-9812, 1663-9812
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!